Stock CRM PZ CORMAY S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company PZ Cormay S.A.

Equities

CRM

PLCMRAY00029

Medical Equipment, Supplies & Distribution

Market Closed - Warsaw S.E.
Other stock markets
 16:55:52 07/05/2024 BST 		5-day change 1st Jan Change
0.61 PLN +0.66% Intraday chart for PZ Cormay S.A. +3.74% +3.74%
2023 PZ Cormay S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 PZ Cormay S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Business Summary

PZ Cormay SA is a Polish-based producer and wholesaler of diagnostic reagents and a distributor of the laboratory equipment. The Company is engaged in the design, manufacture and distribution of a range of products for clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation and specific protein recognition. It offers drugs, biochemical rapid tests and devices such as vacuettes and tubes. PZ Cormay SA provides also biochemical analyzers: ACCENT-300, ACCENT-200, PRESTIGE 24i and LIVIA; hematological analyzers: MYTHIC 18, among others, and urinalysis apparatus: IChem 100. On September 1, 2014, Orphee SA acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee SA.

Number of employees: 222

Sales per Business

PLN in Million2022Weight2023Weight Delta
Hematology
45.5 %
42 49.5 % 37 45.5 % -11.37%
Biochemistry
36.6 %
31 36.3 % 30 36.6 % -2.90%
Immunology
8.8 %
4 4.5 % 7 8.8 % +87.19%
Other
3.2 %
4 4.5 % 3 3.2 % -30.19%
General Analytics
1.9 %
1 1.4 % 2 1.9 % +27.95%
Service
1.3 %
1 1.2 % 1 1.3 % +2.64%
Coagulation
1.0 %
1 0.9 % 1 1.0 % +2.85%
Endomagnetics
0.9 %
- - 1 0.9 % -
Vacutest
0.7 %
1 0.7 % 1 0.7 % -0.49%

Sales per region

PLN in Million2022Weight2023Weight Delta
Other
37.6 %
34 39.8 % 31 37.6 % -9.05%
Poland
22.2 %
14 16.7 % 18 22.2 % +27.84%
Russia
15.4 %
16 19.3 % 13 15.4 % -23.34%
Bangladesh
4.6 %
6 6.9 % 4 4.6 % -36.09%
Ukraine
4.5 %
3 3.1 % 4 4.5 % +38.95%
Mexico
3.7 %
2 2.2 % 3 3.7 % +65.24%
Panama
2.8 %
2 2.3 % 2 2.8 % +16.78%
Philippines
2.4 %
3 3.6 % 2 2.4 % -34.84%
Saudi Arabia
2.4 %
-- 2 2.4 % -
India
2.3 %
2 2.3 % 2 2.3 % -3.32%
Iran
2.2 %
-- 2 2.2 % -

Managers

Managers TitleAgeSince
Flavio Finotello CEO
 Chief Executive Officer - 31/08/17
Marcin Sieczek BRD
 Director/Board Member - 02/01/23
Wojciech Suchowski PRN
 Corporate Officer/Principal - 25/08/14

Members of the board

Members of the board TitleAgeSince
Tomasz Markowski CHM
 Chairman - 29/06/16
Bartosz Marczuk BRD
 Director/Board Member 52 -
Marcin Sieczek BRD
 Director/Board Member - 02/01/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 84,205,008 84,205,008 ( 100.00 %) 0 100.00 %

Shareholders

NameEquities%Valuation
IPOPEMA TFI SA
14.48 %
12,192,786 14.48 % 2 M zł
Generali PTE SA
1.150 %
968,477 1.150 % 142 802 zł
PTE WARTA SA
0.7271 %
612,292 0.7271 % 90 282 zł
Aktia Varainhoito Oy
0.3307 %
278,458 0.3307 % 41 059 zł
Allianz Polska TFI SA
0.3278 %
276,059 0.3278 % 40 705 zł
Pekao Pioneer PTE SA
0.3000 %
252,620 0.3000 % 37 249 zł
Altus TFI SA (Investment Management)
0.1002 %
84,397 0.1002 % 12 444 zł
St. Galler Kantonalbank AG (Private Banking)
0.0475 %
40,000 0.0475 % 5 898 zł
Ardea Alba SA
0.0182 %
15,338 0.0182 % 2 262 zł
KBC TFI SA
0.001563 %
1,316 0.001563 % 194 zł

Company contact information

PZ Cormay SA

Ursynów Business Park 303 Pulawska Street

02-785, Warsaw

+48 22 751 7910

http://www.pzcormay.pl
address PZ Cormay S.A.(CRM)

Group companies

NameCategory and Sector
ORPHÉE SA
Medical Specialties

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Diagnostic & Testing Substances

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

1st Jan change Capi.
PZ CORMAY S.A. Stock PZ Cormay S.A.
+3.74% 12.76M
BIOMÉRIEUX Stock bioMérieux
-0.80% 12.65B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-6.06% 8.01B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+0.69% 5.35B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+24.65% 5.23B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+1.03% 4.69B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-52.61% 3.26B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+7.80% 2.64B
VITROLIFE AB Stock Vitrolife AB
-7.55% 2.23B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-0.96% 1.94B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. CRM Stock
  4. Company PZ Cormay S.A.